Optometry News

Opus Genetics received rare pediatric disease designation from the FDA for its ocular gene therapy designed to treat patients with a form of Leber congenital amaurosis, according to a press release.

Spending at least 15 minutes at a time outside appeared to lead to less myopic shift among elementary school students, according to data published in JAMA Network Open.

A review found that OCT and visual acuity were among the most popular benchmarks in the management of diabetic macular edema in clinical practice guidelines.

Optometry Giving Sight has kicked off its 2024 World Sight Day Challenge fundraiser with the theme, “Giving Together, Seeing Forever,” to celebrate the power of the optometry community and efforts to eradicate uncorrected refractive error.

Proposed changes to the 2025 Medicare Physician Fee Schedule may benefit the field of optometry, according to the American Optometric Association.

Visiox Pharmaceuticals has entered into a definitive merger agreement with Ocuvex Therapeutics, according to a press release.

In his keynote address at this year’s Ending Clinician Burnout Global Summit, Thom Mayer, MD, FACEP, likened the health care practitioners in the audience to the professional football players he routinely treats.

Refractive error, age, sex and race/ethnicity can be predictive factors in determining the probability of myopia onset in prepubescent children, according to a study published in Optometry and Vision Science.

Patients with myopia and myopic astigmatism who underwent LASIK with the Bausch + Lomb Technolas Teneo 317 model 2 excimer laser experienced positive visual and refractive outcomes and a high level of satisfaction, according to a study.

In this Healio Video Perspective from the World Ophthalmology Congress, John D. Sheppard, MD, MMSc, FACS, of Virginia Eye Consultants discusses clinical trial data for Miebo for the treatment of dry eye disease.